Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1917111
Max Phase: Preclinical
Molecular Formula: C47H71N19O11
Molecular Weight: 1078.21
Molecule Type: Protein
Associated Items:
ID: ALA1917111
Max Phase: Preclinical
Molecular Formula: C47H71N19O11
Molecular Weight: 1078.21
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O
Standard InChI: InChI=1S/C47H71N19O11/c1-24-39(71)62-32(13-8-16-56-47(51)52)40(72)63-31(41(73)65-34(18-27-21-53-23-58-27)43(75)66-36(22-67)45(77)61-30(38(48)70)12-7-15-55-46(49)50)11-5-6-14-54-37(69)19-35(60-25(2)68)44(76)64-33(42(74)59-24)17-26-20-57-29-10-4-3-9-28(26)29/h3-4,9-10,20-21,23-24,30-36,57,67H,5-8,11-19,22H2,1-2H3,(H2,48,70)(H,53,58)(H,54,69)(H,59,74)(H,60,68)(H,61,77)(H,62,71)(H,63,72)(H,64,76)(H,65,73)(H,66,75)(H4,49,50,55)(H4,51,52,56)/t24-,30-,31-,32-,33-,34-,35-,36-/m0/s1
Standard InChI Key: XXBFMRLPTTYYQL-UNEHNTILSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1078.21 | Molecular Weight (Monoisotopic): 1077.5580 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Khoo KK, Wilson MJ, Smith BJ, Zhang MM, Gulyas J, Yoshikami D, Rivier JE, Bulaj G, Norton RS.. (2011) Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA., 54 (21): [PMID:21962108] [10.1021/jm200839a] |
Source(1):